Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:06 AM
Ignite Modification Date:
2025-12-25 @ 12:06 AM
NCT ID:
NCT06438458
Eligibility Criteria:
Inclusion Criteria:
* Age over 18 years, of any gender and ethnic background
* Admitted to the intensive care unit
* Able to give informed consent
* Patients with an arterial line as part of their treatment plan.
* Patients able to remain seated in chair for at least 30 minutes
* Patients able to remain supine overnight for at least 6 hours
Exclusion Criteria:
* Delirium or inability to give informed consent
* Inability to understand written information in Dutch
* Patients on artificial ventilation
* Orotracheally intubated patients (spontaneous breathing through a tracheostomy cannula is allowed)
* Patients treated with noradrenaline \> 0.05 ug/kg/min
* Patients treated with argipressin
* Patients who received a blood transfusion within 24 hours before measurements
* Patients who received \> 3 L of fluids within 24 hours before measurements
* Patients who received \> 500 ml of iv fluids within 4 hours of measurements
* Severe restlessness or inability to remain supine for 6 hours before initial blood sampling
* Patients being treated with diuretics
* Patients admitted with:
* Decompensated right heart failure
* Pulmonary hypertension
* Pulmonary embolism
* Active bleeding or risk of \>100 ml blood loss
* Hematological disorder/malignancy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06438458
Study Brief:
Protocol Section:
NCT06438458